Brief: VYNE Therapeutics Announces Granting of Composition of Matter Patent for VYN202

YARROW BIOSCIENCE

16/07/2024 13:17

July 16 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS ANNOUNCES GRANTING OF COMPOSITION OF
MATTER
PATENT FOR VYN202, A NOVEL BD2-SELECTIVE BET INHIBITOR
    * VYNE THERAPEUTICS INC - GRANTED PATENT COVERS COMPOUND IN
VYNE'S
VYN202 PROGRAM AND HAS A 20-YEAR TERM THAT WILL EXPIRE IN JUNE
2042

Source text for Eikon:  ID:nGNXdxQ0S 
Further company coverage:  VYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))